CanSino Claims Lead In COVID-19 Vaccine Race And Takes Swipe At Moderna’s Ethics

Will Be First To Publish Phase II Results

 
• By Andrew McConaghie
  
A scientist in a medical laboratory with a dispenser in his hands is doing an analysis.2019-nCoV; coronavirus; China;
One of several frontrunners, CanSino is gearing up to start make-or-break Phase III trials

More from COVID-19

More from Scrip